This article is a retraction of:
RETRACTED: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Frontiers Editorial Office*Retraction of the Original Article
CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
By Lu T, Zhang L, Zhu W, Zhang Y, Zhang S, Wu B and Deng N (2020). Front. Oncol. 10:1529. doi: 10.3389/fonc.2020.01529
The journal retracts the September 2, 2020 article cited above for the following reasons:
Following publication, concerns were raised regarding manipulation in Figures 5 and 7. An investigation was conducted in accordance with Frontiers’ guidelines and the authors failed to provide a satisfactory explanation.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers. The authors agree to this retraction.
Citation: Frontiers Editorial Office (2021) Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer. Front. Oncol. 11:694036. doi: 10.3389/fonc.2021.694036
Received: 12 April 2021; Accepted: 12 April 2021;
Published: 10 May 2021.
Approved by: Giuseppe Giaccone, Cornell University, United States
Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org